Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

Brooklyn Investment Group reduced its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 34.8% during the 4th quarter, ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human ...

Human Metapneumovirus (HMPV) does not affect pets, but misconceptions about its transmission persist. The virus targets human respiratory systems only, and pets cannot catch or spread HMPV.

The missive, released on Monday, is widely read in the biotech community where he has helped found dozens of companies, including Moderna. Combining human efforts, nature, and AI in what Afeyan ...

“Human Metapneumovirus (HMPV) is a common respiratory virus that causes an upper respiratory infection (like a cold). It is a seasonal disease that usually occurs in the winter and early spring ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

Experts say HMPV is unlike COVID-19 in that it has been around for decades and there is some built-in immunity to it. Most children are infected with the virus by the age of 5. Wang said ...

The rate of infections with the flu-like human metapneumovirus (HMPV) in northern China is declining, a health official said, amid some international concern over a potential pandemic BEIJING ...

The Human Metapneumovirus (HMPV), which has been in the spotlight in recent days, is causing unease despite only a handful of cases being reported in India. As anxiety grows, it’s essential to ...

But scientists at Moderna are in the late stages of testing what could be the first such shot, using mRNA technology against the virus. Here’s what to know about norovirus and where things stand ...